<?xml version="1.0" encoding="UTF-8"?>
<p id="Par44">The association of multifunctional MSNs with antimicrobial drugs allows besides controlled drug release, efficient internalization in the bacterial environment (
 <xref ref-type="bibr" rid="CR111">111</xref>,
 <xref ref-type="bibr" rid="CR152">152</xref>). Drug-loaded mesoporous silica carriers were reported to access bone infections since fluids circulation in this region is very low which reduce drugs bioavailability via conventional administration (
 <xref ref-type="bibr" rid="CR114">114</xref>,
 <xref ref-type="bibr" rid="CR117">117</xref>). In addition, the MSNs specificity can be achieved by easily functionalization improving nanoplatforms action in target sites and controlled drugs release minimizing side effects. Table 
 <xref rid="Tab3" ref-type="table">III</xref> summarized examples of MSNs for bacterial infections treatment as well as drugs type, MSNs-based carriers, microorganisms and drugs absorption and release mechanisms.
</p>
